EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors

類似資料

• Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR mutant Lung Cancer
  著者:: Tricker, Erin M., 等
  出版事項: (2015)
• Non-small-cell lung cancers: a heterogeneous set of diseases
  著者:: Chen, Zhao, 等
  出版事項: (2014)
• Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity
  著者:: Chong, Wei, 等
  出版事項: (2020)
• Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers co-driven by mutant EGFR containing T790M and MET
  著者:: Xu, Lu, 等
  出版事項: (2012)
• TopoIIα prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres
  著者:: d’Alcontres, Martina Stagno, 等
  出版事項: (2014)